Evidence map›Paper›PMID 20222966›Full record

ArticleRetrovirology2010

Tax gene expression and cell cycling but not cell death are selected during HTLV-1 infection in vivo.

Linda Zane, David Sibon, Lionel Jeannin, Marc Zandecki, Marie-Hélène Delfau-Larue, Antoine Gessain, Olivier Gout, Christiane Pinatel, Agnès Lançon, Franck Mortreux and 1 more

Open access · goldAbstract read
In one paragraph

Article in Retrovirology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. A FasFrontiers in immunology · 2017
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 10 institutions in 1 country.

Linda ZaneCNRS UMR5239, Université de Lyon, Oncovirologie et Biothérapies, Centre Léon Bérard, 69008 Lyon, France.
David Sibon
Lionel Jeannin
Marc Zandecki
Marie-Hélène Delfau-Larue
Antoine Gessain
Olivier Gout
Christiane Pinatel
Agnès Lançon
Franck Mortreux
Eric Wattel
Université Claude Bernard Lyon 1 · FRCentre de Recherche en Cancérologie de Lyon · FRCentre Hospitalier Universitaire d'Angers · FRCentre Hospitalier Universitaire Henri-Mondor · FRCentre Léon Bérard · FRCentre National de la Recherche Scientifique · FRFondation de Rothschild · FRHôpital Edouard Herriot · FRInstitut Pasteur · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdult T cell leukemia results from the malignant transformation of a CD4+ lymphoid clone carrying an integrated HTLV-1 provirus that has undergone several oncogenic events over a 30-60 year period of persistent clonal expansion. Both CD4+ and CD8+ lymphocytes are infected in vivo; their expansion relies on CD4+ cell cycling and on the prevention of CD8+ cell death. Cloned infected CD4+ but not CD8+ T cells from patients without malignancy also add up nuclear and mitotic defects typical of genetic instability related to the expression of the virus-encoded oncogene tax. HTLV-1 expression is cancer-prone in vitro, but in vivo numerous selection forces act to maintain T cell homeostasis and are possibly involved in clonal selection.

resultsHere we demonstrate that the HTLV-1 associated CD4+ preleukemic phenotype and the specific patterns of CD4+ and CD8+ clonal expansion are in vivo selected processes. By comparing the effects of recent (1 month) experimental infections performed in vitro and those observed in cloned T cells from patients infected for >6-26 years, we found that in chronically HTLV-1 infected individuals, HTLV-1 positive clones are selected for tax expression. In vivo, infected CD4+ cells are positively selected for cell cycling whereas infected CD8+ cells and uninfected CD4+ cells are negatively selected for the same processes. In contrast, the known HTLV-1-dependent prevention of CD8+ T cell death pertains to both in vivo and in vitro infected cells.

conclusionsTherefore, virus-cell interactions alone are not sufficient to initiate early leukemogenesis in vivo.

Indexed as

Cell DeathCell ProliferationGenes, pXCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell Transformation, ViralGene ExpressionHost-Pathogen InteractionsHumansHuman T-lymphotropic virus 1Leukemia-Lymphoma, Adult T-Cell

Identifiers

PMID20222966
PMCPMC2846874
OpenAlexW2117217972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.